InnoCare Pharma Ltd. (688428)
SSE
Closed
Sep 18, 2026
Day's Range
28.1052 wk Range
19.36Overview - 688428 - InnoCare Pharma Ltd.
Key Statistics
Valuation
Enterprise Value
45.07B
P/E (Trailing)
‪54.78‬
P/E (Forward)
‪-121.47‬
PEG Ratio
‪-121.47‬
Price / Sales (TTM)
‪17.75‬
Price / Book
‪6.39‬
EV / EBITDA
‪57.87‬
Profitability
Gross Margin
‪85.88%‬
Profit Margin
‪33.04%‬
Operating Margin
‪12.47%‬
Return on Assets
‪4.28%‬
Return on Equity
‪12.76%‬
Ownership
Shares Outstanding
1.76B
Float
1.16B
Held by Insiders
‪6.06%‬
Held by Institutions
‪18.39%‬
Price stats
Beta
‪0.39‬
50-Day Avg
‪29.02‬
200-Day Avg
‪25.43‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
4 analysts
Average price target
‪CN¥ 35.23‬Market Cap - 688428 - InnoCare Pharma Ltd.
Peers - 688428 - InnoCare Pharma Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on SSE.
- 688428SSEInnoCare Pharma Ltd.46.51BMarket Cap-4.22%52-week change54.78P/E (Trailing)‪33.04%‬Profit Margin
- 688235SSEBeigene Ltd.363.67BMarket Cap-29.40%52-week change85.57P/E (Trailing)‪10.69%‬Profit Margin
- 688331SSERemeGen Co., Ltd.64.73BMarket Cap+8.05%52-week change10.99P/E (Trailing)‪72.71%‬Profit Margin
- 688796SSEBiocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares53.41BMarket Cap+45.35%52-week change145.83P/E (Trailing)‪21.55%‬Profit Margin
- 688578SSEShanghai Allist Pharmaceuticals Co., Ltd.44.77BMarket Cap-12.78%52-week change16.75P/E (Trailing)‪43.67%‬Profit Margin
- 688336SSESunshine Guojian Pharmaceutical Co., Ltd.34.11BMarket Cap+0.89%52-week change11.10P/E (Trailing)‪69.64%‬Profit Margin
- 603392SSEBeijing Wantai Biological Pharmacy Enterprise Co., Ltd.33.22BMarket Cap-124.77%52-week change826.25P/E (Trailing)‪-18.90%‬Profit Margin
Profile Summary - 688428 - InnoCare Pharma Ltd.
About
InnoCare Pharma Ltd. is a biopharmaceutical company engaged in the discovery, development, and commercialization of innovative treatments for diseases with substantial unmet clinical needs. Focused primarily on oncology and autoimmune diseases, InnoCare develops a robust pipeline of targeted therapies designed to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
